TY  - JOUR
AU  - Carranza-Naval, Maria Jose
AU  - del Marco, Angel
AU  - Hierro-Bujalance, Carmen
AU  - Alves-Martinez, Pilar
AU  - Infante-Garcia, Carmen
AU  - Vargas-Soria, Maria
AU  - Herrera, Marta
AU  - Barba-Cordoba, Belen
AU  - Atienza-Navarro, Isabel
AU  - Lubian-Lopez, Simon
AU  - Garcia-Alloza, Monica
PY  - 2021
DO  - 10.3389/fnagi.2021.741923
SN  - 1663-4365
UR  - https://hdl.handle.net/10668/25235
T2  - Frontiers in aging neuroscience
AB  - Alzheimer's disease is the most common form of dementia, and epidemiological studies support that type 2 diabetes (T2D) is a major contributor. The relationship between both diseases and the fact that Alzheimer's disease (AD) does not have a...
LA  - en
PB  - Frontiers media sa
KW  - Alzheimer's disease
KW  - type 2 diabetes
KW  - liraglutide
KW  - neuronal loss
KW  - hemorrhage
KW  - inflammation
KW  - Glucagon-like peptide-1
KW  - Amyloid-beta plaque
KW  - Mouse model
KW  - Central pathology
KW  - Tau hyperphosphorylation
KW  - Insulin-resistance
KW  - Memory impairment
KW  - Synaptic loss
KW  - App/ps1 mice
KW  - Receptor
TI  - Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer's Disease and Type 2 Diabetes
TY  - research article
VL  - 13
ER  -